In the following section, IR with and without increased SREBP-1c expression and varying dietary intake are simulated to assess to what extent these account for the experimentally observed changes in lipid levels, glucose regulation, ATP levels and metabolic rates in NAFLD [1, 2, 6–9]. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.